- Type / Class
- Equity / Common Stock
- Shares outstanding
- 29,067,614
- Total 13F shares
- 3,142,571
- Share change
- +3,142,571
- Total reported value
- $31,331,000
- Price per share
- $9.97
- Number of holders
- 13
- Value change
- +$31,331,000
- Number of buys
- 13
Quarterly Holders Quick Answers
What is CUSIP 501147102?
CUSIP 501147102 identifies KRYS - Krystal Biotech, Inc. - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Related Filing Research
- Latest 13F filings for newly reported positions.
- Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
- Latest 10-Q/10-K reports for financial context tied to this issuer.
- Recent insider transactions for executive and insider activity.
- SEC investors directory and top value investors for manager drilldown.
- Back to full security ownership history.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
- Newer quarter: Q4 2017
Recent filing periods for CUSIP 501147102:
Institutional Holders of Krystal Biotech, Inc. - Common Stock (KRYS) as of Q3 2017
As of 30 Sep 2017,
Krystal Biotech, Inc. - Common Stock (KRYS) was held by
13 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
3,142,571 shares.
The largest 10 holders included
FMR LLC, RA CAPITAL MANAGEMENT, LLC, Knoll Capital Management, LP, HIGHBRIDGE CAPITAL MANAGEMENT LLC, Tourbillon Capital Partners, L.P., BAKER BROS. ADVISORS LP, Artal Group S.A., SABBY MANAGEMENT, LLC, GOLDMAN SACHS GROUP INC, and TWO SIGMA SECURITIES, LLC.
This page lists
13
institutional shareholders reporting positions in this security
for the Q3 2017 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2017 vs Q4 2025 Across Filers
Q4 2025 holders
331
Q3 2017 holders
13
Holder diff
-318
| Investor | Q4 2025 Shares | Q3 2017 Shares | Share Diff | Share Chg % | Q4 2025 Value $ | Q3 2017 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.